Ameritas Investment Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

Ameritas Investment Partners’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,241	Closed	-$118K	–	3087
2019 Q3	$118K	Hold	6,241	–	–	0.01%	1370
2019 Q2	$73K	Buy	6,241 +1,370	+28%	+$16.6K	﹤0.01%	1698
2019 Q1	$66K	Hold	4,871	–	–	﹤0.01%	1725
2018 Q4	$50K	Hold	4,871	–	–	﹤0.01%	1815
2018 Q3	$81K	Sell	4,871 -530	-10%	-$9.58K	﹤0.01%	1699
2018 Q2	$85K	Hold	5,401	–	–	﹤0.01%	1648
2018 Q1	$69K	Hold	5,401	–	–	﹤0.01%	1731
2017 Q4	$62K	Buy	5,401 +1,356	+34%	+$15.1K	﹤0.01%	1810
2017 Q3	$39K	Hold	4,045	–	–	﹤0.01%	2046
2017 Q2	$46K	Hold	4,045	–	–	﹤0.01%	1964
2017 Q1	$84K	Buy	+4,045	New	+$89.5K	﹤0.01%	1528

Ameritas Investment Partners's ALDR Position: Q4 2019 in Review

Ameritas Investment Partners sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 6,241 shares — an estimated $118K sold.

Ameritas Investment Partners first reported a position in ALDR in Q1 2017 and held it in 11 quarters. The position peaked at $118K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Ameritas Investment Partners reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Ameritas Investment Partners sold 6,241 Alder Biopharmaceuticals shares in Q4 2019, an estimated $118K.
Ameritas Investment Partners first reported a position in Alder Biopharmaceuticals in Q1 2017 and held it in 11 quarters.
Ameritas Investment Partners's Alder Biopharmaceuticals position peaked at $118K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Ameritas Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.